AU7512287A - Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof - Google Patents

Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof

Info

Publication number
AU7512287A
AU7512287A AU75122/87A AU7512287A AU7512287A AU 7512287 A AU7512287 A AU 7512287A AU 75122/87 A AU75122/87 A AU 75122/87A AU 7512287 A AU7512287 A AU 7512287A AU 7512287 A AU7512287 A AU 7512287A
Authority
AU
Australia
Prior art keywords
htlv
transcriptase
expression
iii
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75122/87A
Inventor
Stephen P. Goff
William A. Haseltine
Naoko Tanese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Dana Farber Cancer Institute Inc
Original Assignee
Columbia University in the City of New York
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York, Dana Farber Cancer Institute Inc filed Critical Columbia University in the City of New York
Publication of AU7512287A publication Critical patent/AU7512287A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU75122/87A 1986-05-20 1987-05-20 Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof Abandoned AU7512287A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86515686A 1986-05-20 1986-05-20
US865156 1997-05-29

Publications (1)

Publication Number Publication Date
AU7512287A true AU7512287A (en) 1987-12-22

Family

ID=25344859

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75122/87A Abandoned AU7512287A (en) 1986-05-20 1987-05-20 Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof

Country Status (3)

Country Link
JP (1) JPS63503356A (en)
AU (1) AU7512287A (en)
WO (1) WO1987007296A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2852431B2 (en) * 1988-12-07 1999-02-03 財団法人阪大微生物病研究会 Retroviral proteases, reverse transcriptases and endonucleases, and methods for producing these enzymes
HU209835B (en) * 1988-12-07 1994-11-28 Univ Osaka Res Found Method for producing of retrovirus protease, reverse transcriptase and integrase
US5858646A (en) * 1989-02-23 1999-01-12 University Of Ottawa Modified HIV-pol polypeptide having immunological activity for use as diagnostic reagent
DK0514405T3 (en) * 1990-01-31 1995-07-10 Upjohn Co Strain RAL-4 useful for the preparation of small proteins and peptides
US6080540A (en) * 1990-04-20 2000-06-27 Cold Spring Harbor Laboratory Cloning of mammalian genes in microbial organisms and methods for pharmacological screening
WO1992011028A1 (en) * 1990-12-19 1992-07-09 Epitope, Inc. Hiv reverse transcriptase vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2759053A1 (en) * 1977-12-30 1979-07-12 Uhlin METHOD FOR MANUFACTURING GENE PRODUCTS FROM PLASMID DNA

Also Published As

Publication number Publication date
JPS63503356A (en) 1988-12-08
WO1987007296A1 (en) 1987-12-03

Similar Documents

Publication Publication Date Title
AU1259288A (en) Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids)
AU609390B2 (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
JPS6425800A (en) T-cell epitope of hepatities b virus nucleocapside protein
NZ220653A (en) Hiv env region peptides and d-retro versions thereof
GR3015269T3 (en) Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use.
AU3063389A (en) Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
AU7715687A (en) Pharmaceutical composition of sulindac and tromethamine or sodium bicarbonate
AU8015587A (en) 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
AU7512287A (en) Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof
AU1226288A (en) Processes for the preparation of medicinal compositions, compositions obtained by these processes and use thereof for the preparation of medicines against viral hepatitis b and acquired immunodeficiency syndrome
ZA871766B (en) Acetamide derivatives,their preparation and pharmaceutical compositions containing them
AU2476388A (en) Therapeutic necleosides
EP0311107A3 (en) Anti-hiv active 3'-fluoro-purine-2',3'-dideoxyribosides
IL91356A0 (en) Therapeutic nucleosides,their preparation and pharmaceutical compositions containing them
AU2520692A (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus
DK720588D0 (en) RELATIONSHIPS TO USE IN TREATMENT OR PREVENTION OF HUMAN IMMUNE INFECTIVE VIRUS (HIV) INFECTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
IL81568A0 (en) Plasmids which inhibit human t-cell lymphotropic virus type iii replication
AU3836489A (en) Treatment of immunodeficiency
AU627408B2 (en) Sulfonyl derivatives of thieno-triazolo-diazepines, a preparation process of the same and therapeutic compositions containing them
ZA879452B (en) 5-hydroxyethyl derivatives of oxazolidinone-2,their preparation and their therapeutic uses
EP0311108A3 (en) Anti-hiv active 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
EP0308977A3 (en) Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus